Coronary flow velocity reserve predicts adverse prognosis in women with angina and no obstructive coronary artery disease: results from the iPOWER study

Keyphrases

• Adverse Prognosis 100%
• Angina 100%
• Coronary Flow Reserve 100%
• Non-obstructive Coronary Artery Disease 100%
• Heart Failure 33%
• Coronary Microvascular Dysfunction 33%
• Myocardial Infarction 22%
• Confidence Interval 22%
• Hazard Ratio 22%
• Composite Outcome 22%
• Adverse Outcomes 22%
• Cardiovascular Mortality 11%
• Hospital Admission 11%
• Angina Pectoris 11%
• Multivariate Analysis 11%
• Cox Regression 11%
• All-cause Mortality 11%
• Coronary Artery Disease 11%
• Echocardiography 11%
• Routine Assessment 11%
• Doppler Echocardiography 11%
• Coronary Revascularization 11%
• Valvular Heart Disease 11%
• Microvascular Disease 11%
• Left Anterior Descending Artery 11%
• Obstructive Coronary Artery Disease 11%
• Treatment of Women 11%
• Preventive Management 11%

Medicine and Dentistry

• Angina pectoris 100%
• Coronary Artery Disease 100%
• Coronary Flow Reserve 100%
• Heart Failure 33%
• Coronary Microvascular Dysfunction 33%
• Myocardial Infarction 22%
• Hazard Ratio 22%
• Adverse Outcome 22%
• Cardiovascular System 11%
• Multivariate Analysis 11%
• Apoplexy 11%
• Echocardiography 11%
• Proportional Hazards Model 11%
• All Cause Mortality 11%
• Artery 11%
• Angina Pectoris 11%
• Microangiopathy 11%
• Heart Muscle Revascularization 11%
• Doppler Echocardiography 11%
• Valvular Heart Disease 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Coronary Artery Disease 100%
• Heart Failure 50%
• Heart Infarction 33%
• Adverse Outcome 33%
• Angina Pectoris 16%
• All Cause Mortality 16%
• Valvular Heart Disease 16%
• Microangiopathy 16%